Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06186232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
MinorPrimary completion date: Jan 1, 2026 to Feb 15, 2026
Study completion date: May 1, 2026 to Sep 15, 2026
Start date: Jan 1, 2025 to Mar 10, 2024
NotablePrimary completion date changed from estimate of Jun 1, 2025 to Jan 1, 2026Show 9 more changesShow less
Start date changed from estimate of Oct 1, 2024 to Jan 1, 2025
Trial status changed: Unknown → Completed
Final enrollment: 10 participants (planned 6)
Study sites: 0 to 1
Study completion date changed from estimate of Dec 1, 2025 to May 1, 2026
Eligibility criteria expanded, about 18 words
Secondary endpoints: details revised at 1 of 1 entry
Publications: details revised at 7 of 7 entries
Study description expanded, about 4 words
MinorChangedRegistry marked status Unknown; last known: Not Yet Recruiting
NotableStart date: Jul 1, 2024 to Oct 1, 2024
Trial status: Not Yet Recruiting to Unknown
v4
NotableStart date: Jan 1, 2024 to Jul 1, 2024
Primary completion date: Jan 1, 2025 to Jun 1, 2025
Study completion date: Aug 1, 2025 to Dec 1, 2025
v3
MinorStudy description shortened, about 51 wordsv2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the quantity and quality of bone generated, radiographically and histomorphometrically, after guided bone regeneration (GBR) using a membrane of 3D printed custom made (PMMA) and subsequent stability of delayed implant placement.